The U.S. District Court for the Northern District of Ohio denies the FTC’s bid to prevent company from acquiring its alleged potential competitor (Steris / Synergy Health)

On September 24, 2015, the U.S. District Court for the Northern District of Ohio denied the Federal Trade Commission’s (FTC) bid to enjoin Steris Corporation (Steris) from acquiring its alleged potential competitor, Synergy Health plc (Synergy). The loss breaks a string of victories in merger challenges the FTC has litigated since 2011. Steris and Synergy are the second- and third-largest health care sterilization companies in the world, respectively. In the United States, Steris is one of only two U.S. providers of gamma sterilization services. (Sterigenics International LLC is the other.) Synergy operates more than 36 sterilization facilities outside of the U.S., using both gamma and X-ray sterilization.

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

  • Skadden, Arps, Slate, Meagher & Flom (New York)
  • Skadden, Arps, Slate, Meagher & Flom (New York)
  • Skadden, Arps, Slate, Meagher & Flom (Washington DC)

Quotation

Clifford H. Aronson, Matthew P. Hendrickson, John H. Lyons, The U.S. District Court for the Northern District of Ohio denies the FTC’s bid to prevent company from acquiring its alleged potential competitor (Steris / Synergy Health), 24 September 2015, e-Competitions September 2015, Art. N° 75798

Visites 172

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues